Leukotriene Antagonists and Inhibitors As Modulators of IgE-mediated Reactions

Overview

Journal Springer Semin Immunopathol

Specialty Allergy & Immunology

Date 1993 Jan 1

PMID 8362342

Citations 3

Authors

A W Ford-Hutchinson

Affiliations

Soon will be listed here.

Citing Articles

Leukotriene activity modulation in asthma.

Spector S Drugs. 1997; 54(3):369-84.

PMID: 9279501 DOI: 10.2165/00003495-199754030-00002.

Regulation of leukotriene biosynthesis.

Ford-Hutchinson A Cancer Metastasis Rev. 1994; 13(3-4):257-67.

PMID: 7712588 DOI: 10.1007/BF00666096.

Leukotrienes as a target in asthma therapy.

Chanarin N, Johnston S Drugs. 1994; 47(1):12-24.

PMID: 7510618 DOI: 10.2165/00003495-199447010-00002.

References

Charleson S, Prasit P, Leger S, Gillard J, Vickers P, Mancini J . Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition. Mol Pharmacol. 1992; 41(5):873-9. View

GOLDMAN D, Goetzl E . Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J Exp Med. 1984; 159(4):1027-41. PMC: 2187286. DOI: 10.1084/jem.159.4.1027. View

Payan D, Goetzl E . Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc Natl Acad Sci U S A. 1984; 81(11):3501-5. PMC: 345536. DOI: 10.1073/pnas.81.11.3501. View

Ford-Hutchinson A . Leukotriene B4 in inflammation. Crit Rev Immunol. 1990; 10(1):1-12. View

Rouzer C, Riendeau D, Falgueyret J, Lau C, Gresser M . Inhibition of human leukocyte 5-lipoxygenase by a 4-hydroxybenzofuran, L-656,224. Evidence for enzyme reduction and inhibitor degradation. Biochem Pharmacol. 1991; 41(9):1365-73. DOI: 10.1016/0006-2952(91)90110-q. View

Piper P . Leukotrienes: potent mediators of airway constriction. Int Arch Allergy Appl Immunol. 1985; 76 Suppl 1:43-8. DOI: 10.1159/000233734. View

Ishii A, Nakagawa T, Nambu F, Motoishi M, Miyamoto T . Inhibition of endogenous leukotriene-mediated lung anaphylaxis in guinea pigs by a novel receptor antagonist ONO-1078. Int Arch Allergy Appl Immunol. 1990; 92(4):404-7. DOI: 10.1159/000235172. View

Manning P, Watson R, Margolskee D, Williams V, SCHWARTZ J, OByrne P . Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1990; 323(25):1736-9. DOI: 10.1056/NEJM199012203232504. View

Gillard J, Ford-Hutchinson A, Chan C, Charleson S, Denis D, Foster A . L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 1989; 67(5):456-64. DOI: 10.1139/y89-073. View

10.

Bel E, van der Veen H, Kramps J, Dijkman J, Sterk P . Maximal airway narrowing to inhaled leukotriene D4 in normal subjects. Comparison and interaction with methacholine. Am Rev Respir Dis. 1987; 136(4):979-84. DOI: 10.1164/ajrccm/136.4.979. View

11.

Barnes N, Piper P, Costello J . The effect of an oral leukotriene antagonist L-649,923 on histamine and leukotriene D4-induced bronchoconstriction in normal man. J Allergy Clin Immunol. 1987; 79(5):816-21. DOI: 10.1016/0091-6749(87)90215-6. View

12.

Jones T, Young R, Champion E, Charette L, Denis D, Ford-Hutchinson A . L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist. Can J Physiol Pharmacol. 1986; 64(8):1068-75. DOI: 10.1139/y86-183. View

13.

Dixon R, Diehl R, Opas E, Rands E, Vickers P, Evans J . Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature. 1990; 343(6255):282-4. DOI: 10.1038/343282a0. View

14.

Friedman B, Bel E, Buntinx A, Tanaka W, Han Y, Shingo S . Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am Rev Respir Dis. 1993; 147(4):839-44. DOI: 10.1164/ajrccm/147.4.839. View

15.

Knapp H . Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med. 1990; 323(25):1745-8. DOI: 10.1056/NEJM199012203232506. View

16.

Carter G, Young P, Albert D, Bouska J, Dyer R, Bell R . 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther. 1991; 256(3):929-37. View

17.

Hui K, Barnes N . Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet. 1991; 337(8749):1062-3. DOI: 10.1016/0140-6736(91)91709-4. View

18.

FELDBERG W, Kellaway C . Liberation of histamine and formation of lysocithin-like substances by cobra venom. J Physiol. 1938; 94(2):187-226. PMC: 1393616. DOI: 10.1113/jphysiol.1938.sp003674. View

19.

Morris H, Taylor G, Piper P, Tippins J . Structure of slow-reacting substance of anaphylaxis from guinea-pig lung. Nature. 1980; 285(5760):104-6. DOI: 10.1038/285104a0. View

20.

Jones T, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson A . Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol. 1989; 67(1):17-28. DOI: 10.1139/y89-004. View